Commercialization: Page 17
-
Upfront
BMS Undergoes Brand Transformation Bristol Myers Squibb has revealed a new brand to reflect its evolution in light of its acquisition of Celgene for $74 billion late last year. The changes reflect an updated website, logo, and a change in punctuation — removing the hyphen between Bristol and Myer...
By PharmaVoice Team • April 1, 2020 -
HealthTech
Boehringer-Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox Trend Watch: HealthTech Innovations Continue to Transform Patient Care Boehringer Ingelheim and Carebox Healthcare Solutions have launched MyStudyWindow, a digital platform empowering patients, families, caregivers, an...
By PharmaVoice Team • April 1, 2020 -
Artificial Intelligence
Microsoft Launches $40M Healthcare Artificial Intelligence Program Trend Watch: AI continues to gain traction worldwide in healthcare and pharma applications Microsoft has launched a 5-year, $40 million program called AI for Health, an initiative that will use artificial intelligence tools to add...
By PharmaVoice Team • April 1, 2020 -
Innovator's Corner
COVID-19 The latest drug and vaccine innovations to counter this deadly virus. The rapidly moving target of the coronavirus is challenging the best of the world’s life-sciences innovators, and the landscape changes not only by the day but by the hour. At press time for this issue, these are the m...
By PharmaVoice Team • April 1, 2020 -
Brand Bonds: Agency-Client Relationships
Three successful agency and client teams discuss the importance of a positive working relationship. The Chemistry Click Brian Peters Medexus Pharma Having chemistry with people during the agency selection process is most important. If you don’t have that personal connection, it just becomes work,...
By Robin Robinson • April 1, 2020 -
Commanders & Chiefs: Chief Digital Officers
More and more companies are elevating the role of chief digital officer to oversee a range of strategies and the integration of technology solutions. Nagaraja Srivatsan Data in Use The biggest trend I am tracking is determining how data can be used effectively to make critical and impactful decis...
By Nagaraja Srivatsan • April 1, 2020 -
Executive Perspective: Bioinformatics Is Changing the Face of Discovery and Development: A Conversation with Bill Moss, CEO, Seven Bridges
While the rate of approval of novel life-changing precision medicines is on the rise, the economics facing those who discover, commercialize, and are in need of such medications are untenable. The combination of the increased development costs and more narrowly targeted patient populations of pre...
By Bill Moss • April 1, 2020 -
Letter from the Editor
The patient experience We are excited to publish the third annual Patient Voice issue. This special publication is dedicated to raising the voice of patients and sharing their insights on topics ranging from drug discovery and development through commercialization. We also have tapped nearly 100 ...
By Taren Grom • March 1, 2020 -
Upfront
Teva and Direct Relief Partner to Bring Cancer Medicines to Africa Global HOPE (Hematology-Oncology Pediatric Excellence), a program of Texas Children’s Hospital, Teva Pharmaceutical Industries, and Direct Relief are partnering to provide access to medications in sub-Saharan Africa, where a major...
By PharmaVoice Team • March 1, 2020 -
HealthTech
Apple Working on Preventative Healthcare Technology Trend Watch: Mobile Devices Expand Healthcare Monitoring Capabilities In January, Apple CEO Tim Cook announced the company is investigating in technology that could help identify health risks at an early stage, similar to heart monitoring featur...
By PharmaVoice Team • March 1, 2020 -
Artificial Intelligence
AI-Based Blood Test Predicts Neurodegenerative Disease Progression Trend Watch: AI continues to enhance testing, prediction, and diagnosis A new study illustrates that analysis of blood samples through the use of artificial intelligence can be used to predict disease progression. Researchers at T...
By PharmaVoice Team • March 1, 2020 -
Last Word
USP: 200 Years of Building Trust Ronald Piervincenzi, Ph.D., who has served as CEO of the United States Pharmacopeia (USP) since February 2014, discusses the organization’s evolution over the past 200 years and its strategy for the future. PV: Congratulations on the 200th anniversary of USP. How ...
By Ronald Piervincenzi • March 1, 2020 -
The Power of Patients
Patient engagement is permeating all spheres of the healthcare ecosystem. On the cover… This month’s cover image is a self-portrait painted by Casey Ford, age 19, who has a rare connective tissue disorder, which is characterized by under-developed, absent, or misplaced/misaligned kneecaps in newb...
By Taren Grom • March 1, 2020 -
Patient Gallery
Last year, we were honored to feature the art work of Max Schill, now 11, who remains an active patient advocate, and who helped pass the 21st Century Cure Act. We are excited to continue this tradition with this year’s original artwork by 19-year-old Casey Ford. To expand the patient gallery we ...
By Robin Robinson • March 1, 2020 -
Driving Patient Engagement
A cultural shift throughout pharma is putting patients squarely in the middle of strategic decision-making. Pharmaceutical companies should take a cue from patient advocacy groups to drive patient engagement, and even partner with those advocacy organizations to create better patient experiences ...
By Taren Grom • March 1, 2020 -
Patient-Enhanced Drug Discovery and Development
Patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation. In other industries, it would seem odd not to get input from the end user of a product throughout the development stages. But it seems that pharmaceutical companies — some ...
By Taren Grom • March 1, 2020 -
Patient Relationships: Physicians and Payers
Patients are taking an active role in developing relationships with all stakeholders within their healthcare environment. Over the past several years, the relationship between pharma companies and patients has garnered much of the industry’s attention. But as patients become more empowered, engag...
By Robin Robinson • March 1, 2020 -
A Different Kind of Real-World Evidence: The Key Role That Patient-Provider Dialogue Research Can Play
All roads in healthcare lead to and from the medical visit. Well, maybe not all roads, but nearly all. The medical visit is central to the overarching healthcare structure and it is driven by the dialogue between patient and provider. The healthcare data and research landscape has been changing s...
By Katy Hewett • March 1, 2020 -
Patient Heroes
The definition of a hero is a person who is admired for courage, outstanding achievements, or noble qualities. There is a massive demand for patient-engagement solutions, with predictions that the market for such solutions will reach $30.36 billion by 2026. Patient needs are not only supported by...
By PharmaVoice Team • March 1, 2020 -
Making the Patient an Extension of the Team
The concept of patient-centricity is well embedded throughout EVERSANA and is intrinsically tied to helping the agency’s clients achieve their goals. Kristin LaBounty Phillips believes that the entire agency — with a unified commitment to quality in addressing patients’ needs — embodies the conce...
By Kristin LaBounty Phillips • March 1, 2020 -
Breaking Down Barriers to Bring Patients Equal Access to Top-Quality Care
Patients Always The term “patients first" is not enough, rather it’s “patients always" because patients are our North Star through every stage of development — from discovery to clinical trials to approved treatment. Eve Dryer Executive Director, Patient Advocacy Retrophin All patients should hav...
By Eve Dryer • March 1, 2020 -
Clinical Educators Provide Support Along the Whole Patient Journey
Team Power The teams of clinical educators at VMS BioMarketing are driven to help patients on a one-to-one basis to manage chronic illnesses — in the field or on the phone each day. Taking A Step-Wise Approach to clinical education There is one club that no one wants to join, but for those who wo...
By Clinical Educator Teams • March 1, 2020 -
Upfront
Mylan’s Team in Turkey is Helping Women and Children More than a dozen members of Mylan Turkey recently traveled to Mardin to help open a new toy library at the Cumhuriyet Neighborhood Women-Children Center. Mylan supported the project with the Foundation for the Support of Women’s Work (KEDV) to...
By PharmaVoice Team • Feb. 1, 2020 -
HealthTech
Newly FDA-Approved Ingestible Pill Challenges Struggling Proteus Trend Watch: From ingestibles to implants, medical devices continue to create healthcare solutions The FDA approved an ingestible event marker from the privately held digital health company etectRx. The Florida-based company said th...
By PharmaVoice Team • Feb. 1, 2020 -
Artificial Intelligence
AI Tech Company Partners with Roche for Clinical Trial Work Trend Watch: Adoption of AI in Pharma Continues to Grow Sensyne Health signed its second successive partnership with a major pharmaceutical company at the end of 2019 when it agreed to collaborate with Roche to focus on identifying patie...
By PharmaVoice Team • Feb. 1, 2020